Heart Disease
Study results from and the United States update heart disease research
Published in Cardiovascular Device Liability Week, February 4th, 2007
Study 1: Research findings, "Extent to which accepted serum lipid goals are achieved in a contemporary general medical population with coronary heart disease risk equivalents," are discussed in a new report. "This study examined lipid levels and the use of lipid-altering drugs in a contemporary general medical population without documented coronary heart disease (CHD) but with CHD risk equivalents. On the basis of present national guidelines, the following lipid values (in milligrams per deciliter) were considered optimal for this population: low-density lipoprotein cholesterol <100,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- Business Update
Research and Markets reports on Boston Scientific's merger with Guidant - Business Update
Spectranetics laser system used in neurovascular surgery for first time in U.S. - Heart Disease
Deaths from heart disease down by 35%, Hewitt views results of investment and reform - Medical Devices
Research and Markets report says Cordis Medical Device Company may be expanding - Medicare
Medicare now covers noninvasive ultrasound screening for abdominal aortic aneurysms - Abdominal Aortic Aneurysm
Researchers at University of Federico II publish new data on abdominal aortic aneurysm - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
